Clinical outcomes of a 12-week, first treatment with methylphenidate in an Italian representative sample of children and adolescents with ADHD

Clinical outcomes of a 12-week, first treatment with methylphenidate in an Italian representative sample of children and adolescents with ADHD

Abstract Current clinical guidelines suggest methylphenidate (MPH) as first-line option for treatment of attention-deficit/hyperactivity disorder (ADHD). However, the Lombardy ADHD Registry initiative has recently raised some concerns about discrepant therapeutic approaches between different clinica...

Full description

Saved in:
Bibliographic Details
Main Authors: Alessandro Crippa, Eleonora Rosi, Valentina Mauri, Angela Valli, Maria Nobile, Antonio Salandi, Sara Trabattoni, Massimo Molteni
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Attention-deficit/hyperactivity disorder
Autism spectrum disorders
Comorbidity
Methylphenidate
Childhood
Adolescents
Online Access:https://doi.org/10.1038/s41598-025-10684-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-10684-w

Similar Items